Drug Therapy, Combination
Research News and Information

Saturday, November 21, 2009

Pulmonary tuberculosis presenting as fever without source in a pediatric patient with acute lymphoblastic leukemia.

13 Dec 2009 Children who undergo treatment for malignancies are at high for infection with both typical and opportunistic pathogens. Fever in these children prompts extensive evaluation and empiric treatment with broad-spectrum antimicrobials. In the United ... Read more...

Continuous and intermittent dosing of lonafarnib potentiates the therapeutic efficacy of docetaxel on preclinical human prostate cancer models.

29 Nov 2009 Lonafarnib is a potent, selective farnesyltransferase inhibitor (FTI) undergoing clinical studies for the treatment of solid tumors and hematological malignancies. Preclinically, a number of FTIs, including lonafarnib, interact with taxanes to ... Read more...

Long-term outcomes of keratolimbal allograft for total limbal stem cell deficiency using combined immunosuppressive agents and correction of ocular surface deficits.

30 Oct 2009 OBJECTIVE: To determine the long-term outcomes of keratolimbal allograft (KLAL). METHODS: Scores of such risks as infrequent blinking, blink-related microtrauma, conjunctival inflammation, elevated intraocular pressure, dry eye, symblepharon, ... Read more...

Latest indexed articles for 'Drug Therapy, Combination'

These are the very latest articles for this heading:

• Pulmonary tuberculosis presenting as fever without source in a pediatric patient with acute lymphoblastic leukemia. 13 Dec 2009
• Continuous and intermittent dosing of lonafarnib potentiates the therapeutic efficacy of docetaxel on preclinical human prostate cancer models. 29 Nov 2009
• Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension. 3 Nov 2009
• Long-term outcomes of keratolimbal allograft for total limbal stem cell deficiency using combined immunosuppressive agents and correction of ocular surface deficits. 30 Oct 2009
• Raltegravir, etravirine, and ritonavir-boosted darunavir: a safe and successful rescue regimen for multidrug-resistant HIV-1 infection. 30 Oct 2009
• Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines. 30 Oct 2009
• Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors. 30 Oct 2009
• Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical setting. 30 Oct 2009
• Droperidol: past, present and future. 30 Oct 2009
• A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. 30 Oct 2009
• Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression. 30 Oct 2009
• Life-threatening cardiac toxicity after chewing inverted nut (pinang-wang). 30 Oct 2009
• Psychotic woman with painful abdominal distension. Life-threatening psychotropic drug-induced gastrointestinal hypomotility. 30 Oct 2009
• Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C. 27 Oct 2009
• Clinical practice. Postexposure prophylaxis for HIV infection. 27 Oct 2009
• ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. 24 Oct 2009
• Three-year efficacy of complex insulin regimens in type 2 diabetes. 20 Oct 2009
• Optimal insulin treatment in type 2 diabetes. 20 Oct 2009
• Blood-pressure control and delay in progression of kidney disease in children. 20 Oct 2009
• Strict blood-pressure control and progression of renal failure in children. 20 Oct 2009

See a longer list of these articles.

Technical information about 'Drug Therapy, Combination'

Definition: Therapy with two or more separate preparations given for a combined effect.

Descriptor UI: D004359

Alternative terms: Drug Therapy, Combination; Combination Chemotherapy; Polychemotherapy; Polychemotherapies; Therapy, Combination Drug; Chemotherapy, Combination; Chemotherapies, Combination; Combination Chemotherapies; Combination Drug Therapy; Combination Drug Therapies; Drug Therapies, Combination; Therapies, Combination Drug;

Related Mesh Headings: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Drug Synergism;

Tree Number: E02.319.310;

History Note: 74

Technical Notes: IM when general; NIM when with specific drugs; differentiate from DRUG COMBINATIONS which is single preparation of multiple drugs; note X ref POLYCHEMOTHERAPY: do not confuse with POLYPHARMACY which is available for the use of multiple drugs administered to the same patient